Dominic Tyer

SEPTEMBER 30, 2022

Pharmaceutical companies with a chief marketing officer are thin on the ground, but their number will shortly see a slight increase thanks to a new appointment at Pfizer

Marketing 130

Marketing Pharma Pharmaceutical Consulting 130

European Pharmaceutical Review

SEPTEMBER 30, 2022

Professor Hongsoo Choi’s team at The Department of Robotics and Mechatronics Engineering at the Daegu Gyeongbuk Institute of Science & Technology (DGIST), Korea, developed revolutionary technology that produces over 100 microrobots per minute. The collaboration with Professor Sung-Won Kim’s team at Seoul St. Mary’s Hospital, Catholic University of Korea and Professor Bradley J.

Engineering 126

Engineering Networking Pharmaceutical Manufacturing 126

Pharmaceutical Technology

SEPTEMBER 30, 2022

After several setbacks, bluebird bio bounces back with two major FDA gene therapy approvals. Last month, Zynteglo (betibeglogene autotemcel), or beti-cel, was approved as a one-time potentially curative gene therapy for patients with beta-thalassaemia who require regular blood transfusions. Shortly after this, the FDA announced the accelerated approval of bluebird's Skysona (elivaldogene autotemcel), or eli-cel, on 19 September.

FDA 115

FDA Insurance Patients Marketing 115

MedCity News

SEPTEMBER 30, 2022

Virtual specialty care networks may provide the sort of longitudinal healthcare relationship we haven’t seen since the era of house calls and doctors’ bags—benefiting patients and physicians alike.

Healthcare 104

Healthcare Healthcare Doctors Physicians 104

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Medico Reach

SEPTEMBER 30, 2022

Teledentistry has made dental services easily accessible to patients. Customers can avail dental services right from their comfort. It includes online consultation via video calls, text messages, or live chat. That’s why the teledentistry industry is gradually evolving. In fact, the industry will likely cross $2105.76 million by 2028 , with more teledentistry companies entering the market.

Consulting 98

Consulting Insurance Doctors Prescription 98

MedCity News

SEPTEMBER 30, 2022

There are a few key priorities providers and digital health companies should consider in their efforts to better reach patients — including scaling up their commitment to value-based care and working to engage patients beyond their episodic care needs — according to a recent healthcare innovation panel.

Patients 104

Patients Healthcare Healthcare 104

MedCity News

SEPTEMBER 30, 2022

When patients can travel to a pharmacy or doctor’s office in their own neighborhood, they can reach the site on foot or using public transit. They also have to take less time off work and request childcare less often.

Patients 97

Patients Biopharma 97

Spotio

SEPTEMBER 30, 2022

Whether you’re a software entrepreneur, an executive, or a sales manager , one of the best things that you can do to set yourself up for success is to write a sales action plan that supports your company and helps it to grow. Unfortunately, a lot of business leaders struggle with developing a strategy that can enrich and empower their operations. A sales action plan is the easiest way to lay out your objectives, strategies, and tactics for success, in a way that your whole team can understand.

Sales 96

Sales Prospecting Sales Strategy Leads 96

MedCity News

SEPTEMBER 30, 2022

Novo Nordisk is acquiring global rights to a Ventus Therapeutics drug candidate with potential applications in cardiometabolic disorders such as NASH and chronic kidney disease. The small molecule blocks a protein that has become an attractive target for big pharmaceutical companies, such as Roche and Novartis.

Pharmaceutical 97

Pharmaceutical Biopharma Pharma 97

pharmaphorum

SEPTEMBER 30, 2022

Patient organisations have been celebrating the FDA approval yesterday of Amylyx’ amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that arrived at different conclusions about the drug. The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017.

FDA 82

FDA Doctors Patients Prescription 82

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

SEPTEMBER 30, 2022

Employers are having a difficult time navigating all the point solutions in healthcare. But it’s not necessarily a bad thing, as its generating more competition and forcing companies to get creative. Several experts discussed the topic at MedCity’s Invest Digital Health conference.

Competition 96

Competition Healthcare Healthcare 96

pharmaphorum

SEPTEMBER 30, 2022

Part I. Novel oncologic drugs continue to command premium pricing, driven by a combination of unmet needs, and delivering often-iterative, sometimes-significant improvements in survival or maintenance of a progression-free state. The stable of PD-1/PD-L1 checkpoint inhibitors, led by Keytruda (pembrolizumab), represents the current generation of high value, high price drugs to tackle a variety of cancers in mono- or combination therapy.

Consulting 81

Consulting Marketing Pharma Manufacturing 81

MedCity News

SEPTEMBER 30, 2022

While EHRs are often viewed as essential clinical tools, most were originally designed to facilitate billing operations. By incorporating clinically responsive workflows that readily present the right information to clinicians at the point of care, EHRs can finally fulfill their destiny – to drive better patient care.

Patients 94

Patients 94

Copyright Clearance Center

SEPTEMBER 30, 2022

September 29, 2022 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announced today that RightFind Cite It is now available for Mac users. RightFind Cite It is CCC’s easy-to-use reference management tool that automatically formats bibliographies directly within Microsoft Word with the style and citations its customers use, saving manual work and time.

Management 93

Management Medical 93

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

MedCity News

SEPTEMBER 30, 2022

Of all systematic changes to healthcare, these four adjustments would be easy enough to roll out quickly and would have a massive impact on the country’s health outcomes.

Healthcare 93

Healthcare Healthcare Management 93

Map My Customers

SEPTEMBER 30, 2022

In a world of continual rising costs and inflation, it is more crucial now than ever to implement ways to minimize and control costs within your business. Everyone within an organization can do their part to contribute to this effort including those within the sales team. A sales team is constantly on the go visiting customers and fuel costs on these travels play a huge role in affecting overall operating costs.

Sales 69

Sales CRM Leads Competition 69

MedCity News

SEPTEMBER 30, 2022

An Amylyx Pharmaceuticals drug developed to slow the progression of amyotrophic lateral sclerosis is now approved, making it just the third FDA-approved treatment for the disease. Amylyx will market its new product under the name “Relyvrio.”.

FDA 89

FDA Leads Pharmaceutical Marketing 89

Copyright Clearance Center

SEPTEMBER 30, 2022

The post CCC Launches OA Agreement Intelligence appeared first on Copyright Clearance Center.

98

98

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

pharmaphorum

SEPTEMBER 30, 2022

Denmark’s Novo Nordisk has agreed to pay $70 million to license rights to a drug developed by Ventus Therapeutics with potential in non-alcoholic steatohepatitis (NASH) and several other diseases associated with inflammation. The deal – which includes additional milestones of up to $633 million plus tiered royalties on sales and R&D funding – focuses on VENT-01, the lead drug in Ventus’ peripherally-restricted NLRP3 inhibitor programme, which is currently in preclinical developme

Biopharma 59

Biopharma Specialization Sales Leads 59

Integrity Solutions

SEPTEMBER 30, 2022

It is no secret that costs are on the rise and that finding justification for a price increase is as easy as looking at everyday purchases. From higher grocery bills to soaring costs for the materials and resources required to produce and deliver products and services, we’ve all felt the impact of inflation and other factors that have steadily pushed prices up over the past year or so.

Sales 57

Sales Sales Management Competition Training 57

pharmaphorum

SEPTEMBER 30, 2022

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug for another few years. The latest verdict – in a federal appeals court – has upheld the validity of a key patent on sitagliptin, the active ingredient in Januvia , as well as metformin combinations Janumet and Janumet XR.

Marketing 59

Marketing Sales Competition FDA 59

MedTechVets

SEPTEMBER 30, 2022

SEPTEMBER 30 – For the past several months, MedTechVets was fortunate to be joined by Military Transition and Corporate Veteran Readiness Specialist , Sara Blewett. Her expertise was utilized to evaluate MTV’s program effectiveness and implement improvements to ensure a sustainable future to assist veterans to their career transition goals. “Sara is such a wonderful bundle of knowledge!

Medical 52

Medical Networking Transportation Ethics 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

Pharmaceutical Technology

SEPTEMBER 30, 2022

InflaRx has submitted an application seeking Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its lead candidate, vilobelimab, to treat Covid-19 patients who are critically ill. The latest development comes after the company had encouraging discussions with the agency at a Type B meeting. In addition, vilobelimab received Fast Track designation from the FDA to treat critically ill, mechanically ventilated, intubated patients with the infection.

Food and Drug Administration 52

Food and Drug Administration FDA Food Patients 52

CLD, Inc.

SEPTEMBER 30, 2022

The most impactful and dynamic training deliverables in life sciences focus on the patient. These pieces can help learners have and convey empathy for the burden of disease, discuss the limits and possibilities of treatment, perceive more of the hidden consequences of a disease, and learn about patient and caregiver "wish lists" for managing their disease -- ultimately helping learners better position treatments to HCPs.

Patients 52

Patients Training Management Sales 52

Pharmaceutical Technology

SEPTEMBER 30, 2022

Pheon Therapeutics has announced its launch to progress new antibody-drug conjugates (ADCs) for treating solid tumours. The launch comes after the company raised $68m in a series A financing round led by Brandon Capital, Forbion and Atlas Venture. Seed investor Research Corporation Technologies (RCT) also took part in the funding round. The latest financing will aid the company in progressing its lead ADC programme to clinical proof-of-concept (PoC) and validate the new ADC pipeline. .

Safety 52

Safety Leads Pharmaceutical Patients 52

PharmExec

SEPTEMBER 30, 2022

In episode 118, Paula Brown Stafford, CEO of Novan, discusses the company’s upcoming NDA filing for its topical agent for molluscum contagiosum, what commercialization could look like and her goals for the future.

52

52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Pharmaceutical Technology

SEPTEMBER 30, 2022

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Verismo Therapeutics’ SynKIR-110 to treat mesothelin-expressing mesothelioma patients. A next generation cell therapy approach, SynKIR-110 acts on solid tumours. It is said to be the first product to leverage the new KIR-CAR platform, a modified NK-like receptor for boosting efficacy and persistence against aggressive solid tumours.

Food and Drug Administration 52

Food and Drug Administration FDA Prescription Food 52

pharmaphorum

SEPTEMBER 30, 2022

Biogen and Eisai are riding high on the wave of optimism set in motion by the top-line data drop for Alzheimer’s therapy lecanemab – but a number of breakwaters could lie ahead. First and most obviously is the detailed data from the Clarity AD study reported this week, which will be revealed at the Clinical Trials on Alzheimer’s Congress (CTAD) in November.

Doctors 52

Doctors Side effects Safety Sales 52

PharmaTimes

SEPTEMBER 30, 2022

New formulation may be suitable for large-scale trials and commercial supply in the future

67

67

pharmaphorum

SEPTEMBER 30, 2022

Trusted Johnson & Johnson brands including Tylenol, Aveeno, Neutrogena, Listerine, and Band-Aid are set to fall under the new, independent company name in a next-chapter move of repurposing and modernisation. Johnson & Johnson’s Kenvue – previously the planned New Consumer Health Company – is just one part of the 135-year old company’s plan to reinvigorate its corporate image.

Government 52

Government Consulting Pharma Sales 52

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients